242 related articles for article (PubMed ID: 11181511)
1. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
Cullen MJ; Ling N; Foster AC; Pelleymounter MA
Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
[TBL] [Abstract][Full Text] [Related]
2. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
[TBL] [Abstract][Full Text] [Related]
3. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
4. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
6. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.
Fekete EM; Zhao Y; Szücs A; Sabino V; Cottone P; Rivier J; Vale WW; Koob GF; Zorrilla EP
Br J Pharmacol; 2011 Dec; 164(8):1959-75. PubMed ID: 21627635
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats.
Yeh C; Ting CH; Doong ML; Chi CW; Lee SD; Chen CY
Drug Des Devel Ther; 2016; 10():3281-3290. PubMed ID: 27757017
[TBL] [Abstract][Full Text] [Related]
8. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
9. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
Turnbull AV; Vaughan J; Rivier JE; Vale WW; Rivier C
Endocrinology; 1999 Jan; 140(1):71-8. PubMed ID: 9886809
[TBL] [Abstract][Full Text] [Related]
10. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
11. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
[TBL] [Abstract][Full Text] [Related]
12. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
Kimura Y; Takahashi K; Totsune K; Muramatsu Y; Kaneko C; Darnel AD; Suzuki T; Ebina M; Nukiwa T; Sasano H
J Clin Endocrinol Metab; 2002 Jan; 87(1):340-6. PubMed ID: 11788672
[TBL] [Abstract][Full Text] [Related]
13. The neurobiology of urocortin.
Skelton KH; Owens MJ; Nemeroff CB
Regul Pept; 2000 Sep; 93(1-3):85-92. PubMed ID: 11033056
[TBL] [Abstract][Full Text] [Related]
14. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
15. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
Huang Q; Timofeeva E; Richard D
J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
[TBL] [Abstract][Full Text] [Related]
16. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
Ohata H; Shibasaki T
Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
[TBL] [Abstract][Full Text] [Related]
17. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
Doyon C; Samson P; Lalonde J; Richard D
J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
[TBL] [Abstract][Full Text] [Related]
18. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
[TBL] [Abstract][Full Text] [Related]
19. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
20. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF.
Pelleymounter MA; Joppa M; Carmouche M; Cullen MJ; Brown B; Murphy B; Grigoriadis DE; Ling N; Foster AC
J Pharmacol Exp Ther; 2000 Jun; 293(3):799-806. PubMed ID: 10869378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
